Acute liver failure (ALF) is a life-threatening emergency where the liver loses function rapidly in a person without prior liver disease. Immediate specialist intervention can be life-saving.
Acute liver failure (ALF) is defined as severe acute liver injury with encephalopathy and coagulopathy (INR ≥ 1.5) in a patient without pre-existing liver disease, presenting within 26 weeks of illness onset.
Without treatment, ALF has >80% mortality. With intensive medical management and urgent transplant when indicated, survival rates exceed 60%.
If any of these signs are present in someone with jaundice, do not wait. Seek emergency care and contact Dr. Srinivas immediately.
ICU admission with monitoring of neurological status (encephalopathy grade), coagulation (INR, PT), renal function, and haemodynamics. Central venous and arterial line placement.
Comprehensive viral hepatitis serology, drug history, autoimmune screen, ceruloplasmin (Wilson's), Budd-Chiari imaging. Treatment of specific causes where available (N-acetylcysteine for paracetamol, steroids for AIH).
Cerebral oedema (mannitol, ICP monitoring), renal failure (CRRT), coagulopathy, hypoglycaemia correction, sepsis surveillance and treatment, nutrition support.
Continuous reassessment using King's College Criteria or MELD to determine transplant necessity. Simultaneous listing with ZCCK for deceased donor. LDLT from family member can bypass organ waiting time in urgent cases.
Yes — the majority of ALF cases caused by viral hepatitis E or drug toxicity recover with intensive medical management alone. A transplant is reserved for patients meeting King's College Criteria or MELD-based thresholds, indicating the liver is unlikely to regenerate. Close monitoring by a specialist is essential because the decision window is hours to days, not weeks.
Once encephalopathy worsens to Grade III–IV or coagulopathy becomes severe, simultaneous medical stabilisation and transplant listing must happen — the window is 24–72 hours. Waiting to see if the liver recovers before listing can result in the patient deteriorating beyond the surgical window. Early contact with a liver transplant centre is critical.
A living donor liver transplant (LDLT) uses a portion of a healthy family member's liver. In India, where deceased donor availability is severely limited, LDLT allows bypassing the organ waiting list — a patient can potentially be transplanted within 24–48 hours of donor evaluation. Dr. Srinivas coordinates rapid LDLT workup as part of the emergency management pathway for suitable ALF patients.